Disruption of signaling through SEK1 and MKK7 yields differential responses in hypoxic colon cancer cells treated with oxaliplatin.

Source:http://linkedlifedata.com/resource/pubmed/id/18436711

Download in:

View as

General Info

PMID
18436711